ADNP and ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder: Future studies aimed at translating the current cellular and previous animal studies to clinical practice [51] for better understanding of mutational differences should be undertaken, starting with a clinical trial in ADNP syndrome children, harnessing the NAP (davunetide) enhancement/replacement therapy of deficient ADNP.